To comprehensively clarify the role of Asprosin in NAFLD, Asprosin expression was further tested in PA‐treated AML‐12 cells and Asprosin was found to be overexpressed with the increasing time of PA treatment. The gene discussed is FBN1; the disease is acute myeloid leukemia.